Two Sigma Ventures, LP
- SEC CIK
- 0001878979
Holdings, Q3 2022
Positions as of Sep 30, 2022, filed Nov 14, 2022.SEC
- Positions
- 1
- −1 vs. Q2 2022
- Total value
- $9.61M
- −$6.96M (−42.0%) vs. Q2 2022
Compare with Q2 2022: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q2 2022.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRECURSION PHARMACEUTICALS IN | CL A | 903,400 | $9.61M | 100.00% | −903,400−50.0% | Reduced | View |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are no longer in this filing.
| Security | Class | Shares, Q2 2022 | Value, Q2 2022 | % of portfolio, Q2 2022 |
|---|---|---|---|---|
| ZYMERGEN INC98985X100 | COM | 1,513,727 | $1.86M | 11.24% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q3 2022 | Nov 14, 2022 | 1 | $9.61M | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 2 | $16.57M | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 2 | $17.31M | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 3 | $50.42M | – | SEC |